Investigational Drug Information for Benzoylecgonine
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Benzoylecgonine?
Benzoylecgonine is an investigational drug.
There have been 18 clinical trials for Benzoylecgonine.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2011.
The most common disease conditions in clinical trials are Cocaine-Related Disorders, Impulsive Behavior, and Renal Insufficiency. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), University of Pennsylvania, and Cincinnati MDRU.
Summary for Benzoylecgonine
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 3,903 |
WIPO Patent Applications | 1,269 |
Japanese Patent Applications | 516 |
Clinical Trial Progress | Phase 3 (2011-05-01) |
Vendors | 16 |
Recent Clinical Trials for Benzoylecgonine
Title | Sponsor | Phase |
---|---|---|
Trial Of NS2359 For The Treatment of Cocaine Dependence | Saniona | Phase 2 |
Trial Of NS2359 For The Treatment of Cocaine Dependence | The Dana Foundation | Phase 2 |
Trial Of NS2359 For The Treatment of Cocaine Dependence | University of Pennsylvania | Phase 2 |
Clinical Trial Summary for Benzoylecgonine
Top disease conditions for Benzoylecgonine
Top clinical trial sponsors for Benzoylecgonine
US Patents for Benzoylecgonine
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |